Zoetis Dividends and Buybacks
Dividend criteria checks 4/6
Zoetis is a dividend paying company with a current yield of 1.39% that is well covered by earnings. Next payment date is on 2nd December, 2025 with an ex-dividend date of 31st October, 2025.
Key information
1.4%
Dividend yield
2.8%
Buyback Yield
| Total Shareholder Yield | 4.2% |
| Future Dividend Yield | 1.7% |
| Dividend Growth | 18.1% |
| Next dividend pay date | 02 Dec 25 |
| Ex dividend date | 31 Oct 25 |
| Dividend per share | n/a |
| Payout ratio | 32% |
Recent dividend and buyback updates
Recent updates
Zoetis: High-Quality Compounder For Patient Long-Term Dividend Growth Investors
Nov 03Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Jun 30
Zoetis Inc.'s (NYSE:ZTS) Intrinsic Value Is Potentially 41% Above Its Share Price
Apr 30Zoetis Inc. (NYSE:ZTS) Investors Are Less Pessimistic Than Expected
Apr 02Zoetis: Lots Of Growth Opportunities For This High-Quality Compounder
Mar 25Zoetis: Focusing On The High Margin Segments
Mar 13Zoetis Inc. (NYSE:ZTS) Yearly Results: Here's What Analysts Are Forecasting For This Year
Feb 15Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
Feb 13Is Zoetis (NYSE:ZTS) Using Too Much Debt?
Jan 31Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 33%?
Jan 10The Wall Street Journal Vs. Zoetis
Dec 26Zoetis: Are Competition And Price Increases A Cause For Concern?
Dec 06Zoetis: Healing Paws, Growing Profits
Nov 29Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy
Nov 18Zoetis: A Solid Choice For The Young Dividend Growth Investor
Oct 09Zoetis: Investing In Pet Health And Portfolio Wealth
Sep 26Zoetis: Librela Sales Should Peak 200-300% Above Management's $1B Target
Aug 13Zoetis Q2 Earnings: Harvesting From DTC (Rating Upgrade)
Aug 07Zoetis: A High-Quality Business And Fast Dividend Growth At A Reasonable Price
Jul 03Zoetis: Don't Fret Excessively Over The Animal Healthcare Leader
Jun 11Zoetis: Why The Focus On Companion Animal Segment Will Pay Off
May 22Zoetis: Long-Term Buy Despite Safety Concerns
May 03Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment
Apr 15Zoetis: My Favorite Healthcare Stock Right Now
Mar 21Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness
Feb 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: ZTS's dividends per share have been stable in the past 10 years.
Growing Dividend: ZTS's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Zoetis Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ZTS) | 1.4% |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.6% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (ZTS) (up to 3 years) | 1.7% |
Notable Dividend: ZTS's dividend (1.39%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.48%).
High Dividend: ZTS's dividend (1.39%) is low compared to the top 25% of dividend payers in the US market (4.64%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (32%), ZTS's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (39.9%), ZTS's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/03 05:39 |
| End of Day Share Price | 2025/11/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zoetis Inc. is covered by 37 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Douglas Tsao | Barclays |
| Balaji Prasad | Barclays |